Health Care: Drugs

Transition Therapeutics Inc (TTHI: NASDAQ)

$1.58 n/a | n/a%
07/29/16 - 03:58 PM ET
Company Profile
Price and Volume
Recent Price 1.57
52 Week High 2.75
52 Week Low 0.66
Avg. Daily Vol. (Mil) 0.09
Beta (3 year) 2.56
Share Related Items
Mkt Cap (Mil) 61.04
Shares Out (Mil) 38.88
Float (Mil) 21.68
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 10.90
Current Ratio 11.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 2.94
Price/Cash Flow -3.20
Per Share Data
Earnings -0.52
Sales 0.00
Book Value 0.53
Cash Flow -0.50
Business Summary
Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes.
General Information
101 College Street
Suite 220
Toronto, ON M5G 1L7
Industry : Drugs
Sector: Health Care
Employees: 18
CEO: Dr. Tony F. Cruz
Short Interest
Current Month (Mil) 0.19
Previous Month (Mil) 0.24
Short Interest Ratio (Days) 1.00
Management Effectiveness
Return on Equity n.a.
Return on Assets -78.10
Return on Investments -95.80
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with TTHI

Latest TTHI Headlines from TheStreet

More Financial News for TTHI

Press Releases for TTHI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter